The development of effective immune reactive cancer therapies has been constrained by the lack of delivery systems with precise tumor selectivity. This study leverages an RHOT1/2- mediated fibroblast mitochondrial transfer mechanism to enable tumor-specific uptake within a gold-based nanoplatform, inducing durable antitumor immunity.